<span>Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial &amp; Diagnostic Transition</span>
September 29, 2021

Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial &amp; Diagnostic Transition

Hear Kathy Landshulz, Therapeutic Area Lead, Biomarker Solution Center, Labcorp Oncology, keynote presentation from the World CDx US 2022 conference, "Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial and Diagnostic Transition." The presentation covers deploying the right biomarkers, platforms
Read more »
<span>Reuters Event - Cell &amp; Gene Therapy USA - Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell &amp; Gene Therapies</span>
September 30, 2021

Reuters Event - Cell &amp; Gene Therapy USA - Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell &amp; Gene Therapies

Listen to Maryland Franklin, PhD, Vice President and Enterprise Head of Cell & Gene Therapy, Labcorp Drug Development, focus on addressing the complexity of long-term follow up for cell and gene therapy with a patient-guided approach in her presentation, Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell & Gene Th
Read more »
<span>Digital Pathology Solutions for Drug Development and Diagnostics</span>
November 2, 2021

Digital Pathology Solutions for Drug Development and Diagnostics

There has been a growing body of supporting evidence in the translational research field showing the role genomic- and proteomic-based platforms in enabling more informed and potentially effective therapeutic strategies in clinical development and when appropriate transitioning to diagnostic applications. Hear from Labcorp Drug Development Sr.
Read more »